Bill Text: TX HB3535 | 2023-2024 | 88th Legislature | Introduced


Bill Title: Relating to the medical use of low-THC cannabis by patients with certain medical conditions.

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Introduced - Dead) 2023-03-16 - Referred to Public Health [HB3535 Detail]

Download: Texas-2023-HB3535-Introduced.html
  88R13938 JSC-D
 
  By: Morales Shaw H.B. No. 3535
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the medical use of low-THC cannabis by patients with
  certain medical conditions.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 169.003, Occupations Code, is amended to
  read as follows:
         Sec. 169.003.  PRESCRIPTION OF LOW-THC CANNABIS.  A
  physician described by Section 169.002 may prescribe low-THC
  cannabis to a patient if:
               (1)  the patient is a permanent resident of the state;
               (2)  the physician complies with the registration
  requirements of Section 169.004; and
               (3)  the physician certifies to the department that:
                     (A)  the patient is diagnosed with:
                           (i)  epilepsy;
                           (ii)  a seizure disorder;
                           (iii)  multiple sclerosis;
                           (iv)  spasticity;
                           (v)  amyotrophic lateral sclerosis or
  another motor neuron disorder;
                           (vi)  autism;
                           (vii)  cancer;
                           (viii)  Parkinson's disease;
                           (ix)  cerebral palsy;
                           (x)  a brain tumor;
                           (xi)  vascular insult to the brain;
                           (xii)  a spinal cord disorder;
                           (xiii)  traumatic brain injury;
                           (xiv)  post-polio syndrome;
                           (xv)  muscular dystrophy;
                           (xvi)  myasthenia gravis;
                           (xvii)  peripheral neuropathy;
                           (xviii)  Huntington's disease, Friedreich's
  ataxia, spinocerebellar degeneration, or another [an] incurable
  neurodegenerative disease;
                           (xix) [(ix)]  post-traumatic stress
  disorder; or
                           (xx) [(x)]  a medical condition that is
  approved for a research program under Subchapter F, Chapter 487,
  Health and Safety Code, and for which the patient is receiving
  treatment under that program; and
                     (B)  the physician determines the risk of the
  medical use of low-THC cannabis by the patient is reasonable in
  light of the potential benefit for the patient.
         SECTION 2.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution.  If this
  Act does not receive the vote necessary for immediate effect, this
  Act takes effect September 1, 2023.
feedback